Mono Pharmacare Limited (NSE:MONOPHARMA)

Mono Pharmacare Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	30.9	24.42	9.44	3.51	0.95
Depreciation & Amortization	1.29	1.15	0.51	1.08	1.28
Other Operating Activities	40.08	31.37	13.05	8.66	7.05
Change in Accounts Receivable	-102.97	-97.2	-122.87	-1.74	-20.24
Change in Inventory	-130.94	-96.06	-265.95	-5.73	-11.87
Change in Accounts Payable	91.13	29.26	0.08	20.91	9.8
Change in Other Net Operating Assets	27.48	19.34	-29.66	-24.29	5.18
Operating Cash Flow	-43.03	-87.72	-395.4	2.4	-7.83
Capital Expenditures	-2.26	-1.75	-6.33	-0.14	-0.64
Investment in Securities	-	5.73	-5.88	-	-
Other Investing Activities	-	0	-	-	-
Investing Cash Flow	-2.26	3.98	-12.21	-0.14	-0.64
Short-Term Debt Issued	-	-	195.94	-	-
Long-Term Debt Issued	88.37	-	136.24	5.28	3.45
Total Debt Issued	88.37	-	332.19	5.28	3.45
Short-Term Debt Repaid	-	-	-	-1.69	-5.99
Long-Term Debt Repaid	-	-8.86	-	-	-
Total Debt Repaid	-	-8.86	-	-1.69	-5.99
Net Debt Issued (Repaid)	88.37	-8.86	332.19	3.59	-2.54
Issuance of Common Stock	-	122.87	84.44	2.29	15.82
Repurchase of Common Stock	-	-	-2.66	-	-
Other Financing Activities	-39.73	-30.83	-9.3	-7.42	-6.62
Financing Cash Flow	48.64	83.18	404.67	-1.54	6.66
Miscellaneous Cash Flow Adjustments	0	-	4.67	-0	-0
Net Cash Flow	3.35	-0.55	1.73	0.72	-1.82
Free Cash Flow	-45.29	-89.47	-401.73	2.26	-8.47
Free Cash Flow Margin	-2.69%	-7.31%	-121.21%	0.61%	-2.99%
Free Cash Flow Per Share	-2.56	-5.83	-70.92	0.46	-1.72
Cash Interest Paid	35.53	28.47	8.45	6.55	6.45
Cash Income Tax Paid	13.9	7.3	-	0.76	0.3
Levered Free Cash Flow	-123.34	-144.81	-412.64	-4.74	-14.88
Unlevered Free Cash Flow	-101.14	-127.02	-407.35	-0.65	-10.85
Change in Working Capital	-115.3	-144.66	-418.39	-10.86	-17.12

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.